載入...
Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease
Protease-activated receptors (PARs) are coagulation protease targets, and they increase expression of inflammatory cytokines and chemokines in various diseases. Of all PARs, previous reports have shown that PAR1 or PAR2 inhibition is protective against diabetic glomerular injury. However, how PAR1 a...
Na minha lista:
| 發表在: | Am J Physiol Renal Physiol |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Physiological Society
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294339/ https://ncbi.nlm.nih.gov/pubmed/32200667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00595.2019 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|